Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

W1131 is a STAT3 inhibitor.1 It selectively inhibits the phosphorylation of STAT3 over STAT1, STAT5, JAK2, and Akt in AGS gastric adenocarcinoma cells at 3 µM. W1131 binds to STAT3 in a cell-free assay (Kd = 7.55 µM) and increases the thermal stability of STAT3 in a cellular thermal shift assay (CETSA) using AGS cells when used at a concentration of 1 µM. It also inhibits STAT3 dimerization, nuclear accumulation, and transcriptional activation in cell-based assays. W1131 (3 µM) induces cell death in AGS cells, which can be reversed by Z-VAD-FMK (Z-VA-DL-D(OMe)-FMK; Item No. 27421), ferrostatin-1 (Item No. 17729), liproxstatin-1 (Item No. 17730), deferoxamine (DFO; Item No. 14595), necrosulfonamide (Item No. 20844), or bafilomycin A1 (Item No. 11038). In vivo, W1131 (10 mg/kg) decreases tumor volume and weight in 5-fluorouracil-sensitive and -resistant MGC803 gastric cancer mouse xenograft models.
WARNING This product is not for human or veterinary use.
1. Inhibition of STAT3-